The Latest Cardiac and Vascular News
ENGLEWOOD, Colo., April 12, 2021 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced orders for Q1 2021. Thomas Sandgaard, CEO of Zynex said: “Our order growth in Q1 was strong at […]
Innovative treatment for patients with respiratory and cardiovascular disease expands ZOLL’s critical-care portfolio CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, today announced that it has acquired Respicardia, Inc., a provider of novel implantable neurostimulators for the treatment of moderate to severe […]
An acceleration of development in order to advance the marketing horizon up to 3 years, to conquer an addressable market of over one billion euros Valbiotis presents preclinical data on the plant-derived active substance TOTUM•854, designed to reduce blood pressure, at the Annual Joint Meeting of the European Society of […]
– Single Doses of Investigational ALN-AGT Achieved Sustained Reductions in Serum Angiotensinogen (AGT) at 12 Weeks Resulting in Reduced Blood Pressure – – Durability of AGT Knockdown Supports the Potential of Once Quarterly or Biannual Dosing – – ALN-AGT was Generally Well Tolerated, with No Serious Treatment-Related Adverse Events or […]
MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–Moray Medical announced today that it has closed a total of $5.7 million in seed funding, an increase of $2.4 million compared to the initial raise reported on 01/27/2021. Investors included 415 CAPITAL (lead), Heal Capital, as well as a number of prominent medtech entrepreneurs, such as Fred St. Goar, MD, inventor […]
ENGLEWOOD, Colo., April 9, 2021 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced that it is moving to a new corporate headquarters to accommodate its’ continued growth. The new […]
PARIS–(BUSINESS WIRE)–Regulatory News: CARMAT (Paris:ALCAR) (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total artificial heart, aiming to fulfill an unmet medical need by providing a therapeutic alternative to people suffering from end-stage biventricular heart failure, today announces the issuance of a second tranche of 650,000 equity […]
– New enhancements to first-of-its-kind device uniquely developed for the difficult-to-treat tricuspid valve – Next-generation therapy offers enhanced leaflet grasping feature and new clip sizes to fit each patient’s complex tricuspid valve anatomy – TriClip G4 makes treatment more customizable, expanding options for physicians seeking innovative transcatheter structural heart solutions […]
KIRKLAND, Wash., April 7, 2021 /PRNewswire/ — Cardiac Dimensions announced a published second individual patient data meta–analysis demonstrating clinically significant outcomes for the Carillon Mitral Contour System®. This publication, in addition to the several others recently published on the Carillon device, continues the series of excellent results for this transcatheter-based indirect annuloplasty device. […]
SAN FRANCISCO, April 8, 2021 /PRNewswire/ — Invitae Corporation (NYSE: NVTA), a leading medical genetics company, has joined eMERGE Network, a nationwide effort organized and funded by the National Human Genome Research Institute (NHGRI) that connects genetic data and electronic medical record (EMR) systems to advance the use of genetics in healthcare. As a new clinical affiliate, […]
